Clinigene deploys SAS Clinical Data Management solution to accelerate clinical research

SAS, the leader in business analytics software and services has announced that Clinigene International Limited, a full-service Clinical Research Organization that partners with global pharmaceutical and biotechnology companies, has deployed SAS Clinical Data Management – PheedIt solution to accelerate clinical research. SAS PheedIt is a highly efficient, cost effective and easy-to-use clinical data management solution (CDMS).

Mr. Manoj Yasodharan, Manager – Clinical Data Management & Biostatistics, Clinigene International Ltd said SAS PheedIt provides a complete solution for clinical data management and analysis. We have successfully reduced the time for setup, for new trial projects. SAS partnership has helped us in setting up our own server thereby giving us complete control over the entire data management, analysis and reporting process.

SAS is a de facto standard in the Life Science industry for statistical analysis and clinical trial reporting. SAS Clinical Data Management solution incorporates powerful Electronic Data Capture (EDC) and data management features which provide a robust data entry portal integrated with ability to handle data transformation, data imports and exports, analysis and reporting.

Mr. Sudipta K Sen, Regional Director South-East Asia, CEO & MD SAS India said that the  wealth of expertise and extensive track record positions us well as a leader in this field. This yet another win for SAS ensures our commitment as a partner to help organizations make a clear impact on their business goals.

SAS Clinical Data Management – PheedIT comes with its own data storage thereby eliminating need for separate database. This data storage is used by the SAS PheedIT report engine to generate reports, graphs and other visualizations, and can be easily used by internal or external statisticians.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top